Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes

Epigenetics and Chromatin

Volumn 9, Issue 1, 2016, Pages 1-12

  Wiersma, Maaike ^a   Bussiere, Marianne ^a,b   Halsall, John A ^a   Turan, Nil ^a   Slany, Robert ^c   Turner, Bryan M ^a   Nightingale, Karl P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chromatin; Gene regulation; Histone modification; MLL1 complex; Signal transduction

Indexed keywords

HISTONE H3; KMT2A PROTEIN; LYSINE; METHYLTRANSFERASE; MSK1 PROTEIN; PROTEIN KINASE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELLS BY BODY ANATOMY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE; GENE ACTIVITY; GENE CONTROL; GENE SILENCING; GENE TARGETING; HISTONE METHYLATION; HOXA4 GENE; HOXA5 GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 84994390878     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/s13072-016-0103-3     Document Type: Article

References (72)

1. Rao RC, Dou Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer. 2015;15(6):334-46.
2. Schuettengruber B, et al. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol. 2011;12(12):799-814.
3. Milne TA, et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10(5):1107-17.
4. Cui K, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4(1):80-93.
5. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7(11):823-33.
6. Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333-9.
7. van Nuland R, et al. Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Mol Cell Biol. 2013;33(10):2067-77.
8. Patel A, et al. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem. 2009;284(36):24242-56.
9. Dou Y, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol. 2006;13(8):713-9.
10. Hughes CM, et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell. 2004;13(4):587-97.
11. Yokoyama A, Cleary ML. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell. 2008;14(1):36-46.
12. Mo R, Rao SM, Zhu YJ. Identification of the MLL2 complex as a coactivator for estrogen receptor alpha. J Biol Chem. 2006;281(23):15714-20.
13. Tyagi S, et al. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol Cell. 2007;27(1):107-19.
14. Lee J, et al. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc Natl Acad Sci USA. 2009;106(21):8513-8.
15. Patel A, et al. A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex. J Biol Chem. 2008;283(47):32162-75.
16. Wu L, et al. ASH2L regulates ubiquitylation signaling to MLL: trans-regulation of H3 K4 methylation in higher eukaryotes. Mol Cell. 2013;49(6):1108-20.
17. Buecker C, Wysocka J. Enhancers as information integration hubs in development: lessons from genomics. Trends Genet. 2012;28(6):276-84.
18. Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol Cell. 2013;49(5):825-37.
19. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell. 2007;25(1):15-30.
20. Ruthenburg AJ, et al. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol. 2007;8(12):983-94.
21. Nayak A, et al. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation. Mol Cell. 2014;55(1):47-58.
22. Hsieh JJ, Cheng EH, Korsmeyer SJ. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell. 2003;115(3):293-303.
23. Hsieh JJ, et al. Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization. Mol Cell Biol. 2003;23(1):186-94.
24. Yokoyama A, et al. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood. 2002;100(10):3710-8.
25. Yokoyama A, et al. MLL becomes functional through intra-molecular interaction not by proteolytic processing. PLoS ONE. 2013;8(9):e73649.
26. Daser A, Rabbitts TH. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 2004;18(9):965-74.
27. Zeleznik-Le NJ, Harden AM, Rowley JD. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc Natl Acad Sci USA. 1994;91(22):10610-4.
28. Birke M, et al. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res. 2002;30(4):958-65.
29. Nakamura T, et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell. 2002;10(5):1119-28.
30. Ernst P, et al. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol. 2001;21(7):2249-58.
31. Arai M, Dyson HJ, Wright PE. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain. FEBS Lett. 2010;584(22):4500-4.
32. Dou Y, et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell. 2005;121(6):873-85.
33. Nightingale KP, et al. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem. 2007;282(7):4408-16.
34. Boudadi E, et al. The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenet Chromatin. 2013;6(1):11.
35. Dyson MH, et al. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. J Cell Sci. 2005;118(Pt 10):2247-59.
36. Soloaga A, et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 2003;22(11):2788-97.
37. McCoy CE, et al. MSK1 activity is controlled by multiple phosphorylation sites. Biochem J. 2005;387(Pt 2):507-17.
38. Arthur JS. MSK activation and physiological roles. Front Biosci. 2008;13:5866-79.
39. Vermeulen L, et al. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003;22(6):1313-24.
40. Guenther MG, et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci USA. 2005;102(24):8603-8.
41. Deak M, et al. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998;17(15):4426-41.
42. Hess JL, et al. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood. 1997;90(5):1799-806.
43. Terranova R, et al. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc Natl Acad Sci USA. 2006;103(17):6629-34.
44. Jude CD, et al. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell. 2007;1(3):324-37.
45. Drobic B, et al. Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res. 2010;38(10):3196-208.
46. Sabbattini P, et al. An H3K9/S10 methyl-phospho switch modulates Polycomb and Pol II binding at repressed genes during differentiation. Mol Biol Cell. 2014;25(6):904-15.
47. Karmodiya K, et al. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genom. 2012;13:424.
48. Barski A, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823-37.
49. Bannister AJ, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. 2001;410(6824):120-4.
50. Eskeland R, Eberharter A, Imhof A. HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol. 2007;27(2):453-65.
51. Fischle W, et al. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature. 2005;438(7071):1116-22.
52. Mateescu B, et al. Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep. 2004;5(5):490-6.
53. Vicent GP, et al. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell. 2006;24(3):367-81.
54. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343-9.
55. Kuzmichev A, et al. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of zeste protein. Genes Dev. 2002;16(22):2893-905.
56. Tie F, et al. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development. 2009;136(18):3131-41.
57. Yuan W, et al. H3K36 methylation antagonizes PRC2-mediated H3K27 methylation. J Biol Chem. 2011;286(10):7983-9.
58. Schmitges FW, et al. Histone methylation by PRC2 is inhibited by active chromatin marks. Mol Cell. 2011;42(3):330-41.
59. Xu C, et al. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc Natl Acad Sci USA. 2010;107(45):19266-71.
60. Gehani SS, et al. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol Cell. 2010;39(6):886-900.
61. Lau PN, Cheung P. Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci USA. 2011;108(7):2801-6.
62. Sawicka A, et al. H3S28 phosphorylation is a hallmark of the transcriptional response to cellular stress. Genome Res. 2014;24(11):1808-20.
63. Terrenoire E, et al. Immunostaining of modified histones defines high-level features of the human metaphase epigenome. Genome Biol. 2010;11(11):R110.
64. White DA, Belyaev ND, Turner BM. Preparation of site-specific antibodies to acetylated histones. Methods. 1999;19(3):417-24.
65. Halsall JA, et al. Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response. Epigenet Chromatin. 2015;8:29.
66. O'Neill LP, Turner BM. Immunoprecipitation of native chromatin: NChIP. Methods. 2003;31(1):76-82.
67. Breiling A, Orlando V. Binding sights in chromatin by X-ChIP. In: Mapping protein/DNA interactions by cross-linking. Paris: Institut national de la sante et de la recherche medicale (INSERM); 2001.
68. Kuo MH, Allis CD. In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment. Methods. 1999;19(3):425-33.
69. Bonifacino, JS, Dell'Angelica EC, Springer TA. Immunoprecipitation. Curr Protoc Immunol. 2001;Chapter 8:Unit 8.3. doi:10.1002/0471142735.im0803s41.
70. Harlow E, Lane D. Immunoprecipitation: purifying the immune complexes. CSH Protoc. 2006;2006(4). doi:10.1101/pdb.prot4536.
71. Schroter H, et al. DNA intercalators induce specific release of HMG 14, HMG 17 and other DNA-binding proteins from chicken erythrocyte chromatin. EMBO J. 1985;4(13b):3867-72.
72. Lai JS, Herr W. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci USA. 1992;89(15):6958-62.